Cello Health BioConsulting
  • menu
  • Home
  • About us
    • Why We’re Different
    • Our Team
    • Mission, Vision & Values
  • Capabilities
    • Common Client Dilemmas
    • Opportunity Assessments
    • Opportunity Search and Evaluation
    • Portfolio and Platform Strategy
    • Business Development & Partnering Strategy
    • Market Access Strategy
    • Early Stage Strategy
  • Our Insights
    • News
    • Presentations
    • Testimonials
    • Events
  • Careers
    • Current Opportunities
    • A Day in the Life
    • Our Culture

Our Insights

Reconsidering Relevance in Oncology: Is the Market Immune to Your Non-IO Assets?

Reconsidering Relevance in Oncology: Is the Market Immune to Your Non-IO Assets?

Oncology | February 18, 2016
More +
The Future is Now: Dealing in a Transformed Healthcare Environment

The Future is Now: Dealing in a Transformed Healthcare Environment

Industry Presentation | LES | November 10, 2015
Download PDF +
Web Panel Discussion: What’s Hot & What’s Not in Immuno-Oncology Licensing Part 1

Web Panel Discussion: What’s Hot & What’s Not in Immuno-Oncology Licensing Part 1

Oncology | October 20, 2015
Download PDF +
Boosting Immuno-Oncology Therapies to the Next Level: New Combinations & Approaches

Boosting Immuno-Oncology Therapies to the Next Level: New Combinations & Approaches

Oncology | July 23, 2015
More +
Web Panel Discussion: What’s Hot & What’s Not in Gene Therapies for Rare Disorders

Web Panel Discussion: What’s Hot & What’s Not in Gene Therapies for Rare Disorders

Gene & Cell Therapy | Payer | May 6, 2015
More +
Changes to Biopharma’s External Ecosystem That Will Bring Permanent Changes to the Biopharmaceutical Industry

Changes to Biopharma’s External Ecosystem That Will Bring Permanent Changes to the Biopharmaceutical Industry

Industry Presentation | April 30, 2015
Download PDF +
Aducanumab: Hype, or Headway for the Alzheimer’s Amyloid Hypothesis?

Aducanumab: Hype, or Headway for the Alzheimer’s Amyloid Hypothesis?

CNS | April 13, 2015
More +
The Dash to Treat NASH, The Next Big Global Epidemic

The Dash to Treat NASH, The Next Big Global Epidemic

Nash/Fibrosis | March 9, 2015
More +
2014 Cardiometabolic Projects To Watch

2014 Cardiometabolic Projects To Watch

CV & Metabolic | November 21, 2014
Download PDF +
Foundational Changes in the Biopharmaceutical and Healthcare Macro Environments . . . and the Impacts on Licensing & Business Development

Foundational Changes in the Biopharmaceutical and Healthcare Macro Environments . . . and the Impacts on Licensing & Business Development

Industry Presentation | October 7, 2014
Download PDF +
  2. ←
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
  12. →

Search

Elsewhere

Let’s work together

Contact us

  • Cello Health BioConsulting
  • 25-B Hanover Road
  • Suite 320
  • Florham Park, NJ
  • 07932
  • USA
  • +1 973 292 5001
  •  
  • Part of Cello Health plc

    Follow us

    Cello Health BioConsulting

    ©2021 Defined Health, now known as Cello Health BioConsulting | Privacy policy.

    View Presentation

    View Presentation

    Please fill the form to access the presentation.
    • This field is for validation purposes and should be left unchanged.

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Defined Health, now known as Cello Health BioConsulting
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    3rd Party Cookies

    This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

    Keeping this cookie enabled helps us to improve our website.

    Please enable Strictly Necessary Cookies first so that we can save your preferences!